-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLes merTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLes merEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLes merEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Les merThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Les merShaping capital markets for future generations
IPO Valbiotis
23/06/2017
Listing of Valbiotis on Euronext
Sébastien Peltier, CEO of Valbiotis, opens the trading day in Paris.
Valbiotis is a biopharmaceutical company specializing in the research and development of preventive and therapeutic products based on polymolecular complexes indicated at specific stages of progression of chronic metabolic pathologies such as type 2 diabetes, obesity, dyslipidemia or NASH (Non-Alcoholic Steatosis Hepatic).